HIMS

Hims & Hers Health, Inc.

$19.13

-16.61%
SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryUnited States

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services.

Source: Yahoo Finance
AI summary

Price & performance

1M-38.1%
3M-39.8%
YTD-42.7%
1Y-53.4%
52-week range—
Beta2.34
Full chart and returns against a benchmark

Q-Score

62/ 100

Quality against peers; 50 is the peer median.

Growth77
Risk46
Performance69
Valuation49
Profitability56
Leverage53
Sentiment14
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$2.3B+59.0%
Net income$128.4M+1.8%
Net margin5.5%-3.1 pts
Historical fundamentals

Revenue exposure

6%of revenue from outside the US
United States94%
Non-US6%
Regions, segments, customers and suppliers

Valuation

HIMSIndustryP/E—35.25P/S1.562.74EV/EBITDA—16.35P/B12.562.46PEG—0.87
Dividend yield0.00%
Every valuation metric

Earnings

Nov 9next report, after the close
EPS estimate$0.15
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate